Microskin granted approval from Saudi FDA

Top Quote Microskin PLC (GXG: MSKN), a revolutionary second skin technology company, has received approval from the Saudi FDA to import its product allowing operations to commence immediately. The company produces a simulated second skin individually formulated to color correct a range of conditions. Approval from the Saudi FDA marks a major milestone for Microskin's development in the Middle East. End Quote
  • (1888PressRelease) July 31, 2013 - Microskin PLC (GXG: MSKN), a revolutionary second skin technology company, has received approval from the Saudi FDA to import its product allowing operations to commence immediately in Riyadh, Saudi Arabia.

    The company produces a simulated second skin individually formulated to color correct a range of conditions such as dermatitis, eczema, psoriasis and vitiligo.

    Microskin PLC's wholly owned subsidiary, Microskin International, has already achieved considerable success both in Australia and overseas including establishing franchises in the US, Europe, the Middle East and Indonesia.

    Executive chairman, Barry Amor, says approval from the Saudi FDA marks a major milestone for Microskin's development in the Middle East, as FDA process' can take up to five years to complete.

    "The Middle East has a high incidence of vitiligo and other skin conditions, so receiving approval from the Saudi FDA provides us with a great opportunity to reach new clients and provide them with effective solutions for their skin issues," Mr Amor says.

    "Our agreement with The Light Clinic in Riyadh, which is considered to be one of the largest vitiligo treatment centres in the world, will see that Microskin is available to approximately 18,000 patients and eight sister clinics.

    "We intend to use this momentum to investigate other franchising options in Jedda followed by Dubai."

    The overseas expansion of Microskin in the Middle East has furthered the company's geographic reach, capturing new markets that weren't previously exposed to the product.

    Approval granted by the Saudi FDA to import Microskin into Saudi Arabia is an indicator of the company's ability to garner attention worldwide.

    Microskin have utilised a franchise model to expand the business since 2010, when they opened their first clinic outside Australia at the Laser and Skin Surgery Center of New York.

    Each clinic has facilities to undertake computer skin tone matching for patients, as well as training in how to apply the product to their own skin.

    For more information visit www.microskin.com.au

    For all media enquiries contact Bruce Nelson on +61 (0) 423 403 449.

    About Microskin

    The concept of Microskin, a world-first skin simulation technology, was originally conceived after realising that make-up was the only method of concealing or camouflaging skin conditions. What transpired after many years of research into cosmetic chemistry as well as developing specially designed software used to read human skin, was a system to develop a spray-on simulated application individually formulated for each client's skin. Microskin will not rub off, is completely waterproof, allows the skin to breath and sweat, and lasts for several days. Since the opening of its first clinic in Brisbane in July 2005, Microskin has assisted people from all over the world with skin related conditions such as, vitiligo, birthmarks, burns, eczema, lupus, keloid scarring.

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information